Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Christopher M Pieczonka , MD

Urology โ€ข Syracuse, NY

Active NPI 1376530121 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

1226 E Water St
Syracuse, NY 132101155

Call 3154784185 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1226 E Water St

Syracuse, NY 132101155

Telephone 3154784185
Fax 3154780840
Organization at the Same NPPES Address or Phone
Associated Medical Professionals Of Ny, Pllc Facility NPI 1467659060

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 2 distinct group names: Associated Medical Professionals Of Ny Pllc; Florida Urology Center Pa. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

State University Of New York At Buffalo School Of Medicine

Graduation Year

1997

Medicare patients

1,125 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider, 2024.

Medicare-allowed amount

About $1,180,120 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

Paid by Medicare

About $934,984 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

30-day fills

3,824 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$10,650,721 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers โ€“ by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $221,773.60 across 216 records.

By nature of payment (3 largest of 6)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $107,172.46 across 29 records.
  • Consulting Fee: $92,996.81 across 22 records.
  • Travel and Lodging: $12,980.83 across 35 records.

Reporting-company totals (3 largest of 28)

  • Janssen Pharmaceuticals, Inc: $86,868.70 across 74 records.
  • IMMUNITYBIO, INC.: $74,969.24 across 20 records.
  • Bayer Healthcare Pharmaceuticals Inc.: $21,578.88 across 16 records.

Research and ownership records are not included in these totals; they are in the table below.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

29 years (graduated 1997)

CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โ€œDoes your provider accept Medicare as full payment?โ€

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Pieczonka has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Pieczonka as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Syracuse and New York

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Urology in Syracuse, NY (2024, 35 clinicians with data). Median for this group: 708. Middle half: 332 to 4,137.

More Medicare Part B services than 95% of clinicians listed under Urology in New York (2024, 682 clinicians with data). Median for this group: 984. Middle half: 433 to 3,510.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Syracuse, NY (2024, 35 clinicians with data). Median for this group: $65,921. Middle half: $24,720 to $170,602.

A higher Medicare-allowed amount than 95% of clinicians listed under Urology in New York (2024, 682 clinicians with data). Median for this group: $98,980. Middle half: $38,082 to $248,195.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Urology in Syracuse, NY (2024, 35 clinicians with data). Median for this group: $48,816. Middle half: $18,892 to $126,237.

A higher Medicare payment amount than 95% of clinicians listed under Urology in New York (2024, 682 clinicians with data). Median for this group: $74,433. Middle half: $28,028 to $186,911.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Urology in Syracuse, NY (2024, 38 clinicians with data). Median for this group: 687. Middle half: 256 to 1,104.

More Part D prescriptions than 80% of clinicians listed under Urology in New York (2024, 758 clinicians with data). Median for this group: 896. Middle half: 208 to 1,938.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Urology in Syracuse, NY (2024, 38 clinicians with data). Median for this group: $65,440. Middle half: $15,951 to $140,540.

A higher Part D drug cost than 95% of clinicians listed under Urology in New York (2024, 758 clinicians with data). Median for this group: $77,328. Middle half: $11,805 to $270,438.

45 active clinicians are listed under Urology with a practice address in Syracuse, NY (1,106 in New York).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Syracuse

64.4% of these 45 clinicians have the CMS telehealth indicator.

82.2% of these 45 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo ยท Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments ยท Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 โ€“ December 31, 2025): 259 records totaling $275,426.05.

Manufacturer Payment Nature Product Type Amount ($)
IMMUNITYBIO, INC.
Consulting Fee
Cash or cash equivalent
ANKTIVA General $19,553.81
IMMUNITYBIO, INC.
Consulting Fee
Cash or cash equivalent
ANKTIVA General $18,000.00
IMMUNITYBIO, INC.
Consulting Fee
Cash or cash equivalent
ANKTIVA General $17,100.00
Dendreon Pharmaceuticals LLC
General
Cash or cash equivalent
PROVENGE Research $8,520.00
Astellas Pharma US Inc
Consulting Fee
Cash or cash equivalent
Xtandi General $7,500.00
Bayer Healthcare Pharmaceuticals Inc.
Consulting Fee
Cash or cash equivalent
Nubeqa General $7,050.00
SUN PHARMACEUTICAL INDUSTRIES INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
In-kind items and services
YONSA General $6,798.96
IMMUNITYBIO, INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ANKTIVA General $6,175.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $6,075.00
Dendreon Pharmaceuticals LLC
General
Cash or cash equivalent
PROVENGE Research $5,720.00
Bayer Healthcare Pharmaceuticals Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
Nubeqa General $5,513.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
RYBREVANT General $5,070.00
Dendreon Pharmaceuticals LLC
General
Cash or cash equivalent
PROVENGE Research $4,970.00
Dendreon Pharmaceuticals LLC
General
Cash or cash equivalent
PROVENGE Research $4,970.00
IMMUNITYBIO, INC.
Consulting Fee
Cash or cash equivalent
ANKTIVA General $4,560.00
Novartis Pharmaceuticals Corporation
Consulting Fee
Cash or cash equivalent
โ€” General $4,200.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B ยท Data Year 2024
Reporting Year:

CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ€“2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ€“ by Provider and Service data, 2017โ€“2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J0897 Injection, denosumab, 1 mg
19,560 66 $41.67 $25.45
J1952 Leuprolide injectable, camcevi, 1 mg
4,326 80 $197.00 $56.65
36415 Insertion of needle into vein for collection of blood sample
979 665 $25.82 $8.40
81003 Automated urinalysis test
921 529 $12.00 $2.19
J9030 Bcg live intravesical instillation, 1 mg
850 12 $6.40 $2.85
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
600 338 $49.67 $15.47
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
556 308 $265.00 $121.51
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
456 313 $180.00 $84.79
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
288 30 $1666.67 $630.62
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
239 30 $124.00 $60.03
96372 Injection of drug or substance under skin or into muscle
183 65 $43.18 $13.66
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
144 101 $79.00 $32.90
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
116 20 $1500.00 $178.47
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
100 15 $123.00 $59.33
76770 Complete ultrasound scan behind abdominal cavity
68 67 $184.00 $68.10
51798 Ultrasound measurement of bladder capacity after voiding
63 59 $46.00 $10.41
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
51 50 $105.00 $53.14
99441 Telephone medical discussion with physician, 5-10 minutes
49 41 $111.00 $51.53
52000 Diagnostic exam of bladder and urethra using an endoscope
42 41 $730.00 $226.18
76775 Limited ultrasound scan behind abdominal cavity
39 39 $130.00 $30.63
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
36 18 $94.00 $45.96
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
32 30 $3550.00 $1380.65
99442 Telephone medical discussion with physician, 11-20 minutes
32 28 $183.00 $86.57
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
26 21 $355.00 $173.10
51720 Instillation of anti-cancer drug into bladder
18 13 $215.00 $83.84

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D ยท Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Orgovyx Relugolix 359 11,010 $995,004.40 52
Tamsulosin Hcl Tamsulosin Hcl 242 18,642 $3,853.40 72
Abiraterone Acetate Abiraterone Acetate 231 7,230 $605,833.32 25
Nubeqa Darolutamide 193 5,970 $2,536,994.52 23
Erleada Apalutamide 186 5,760 $2,739,733.16 26
Xtandi Enzalutamide 182 6,240 $2,966,804.06 24
Prednisone Prednisone 144 6,812 $775.04 27
Finasteride Finasteride 135 11,970 $2,233.61 44
Silodosin Silodosin 119 8,370 $11,405.43 33
Alfuzosin Hcl Er Alfuzosin Hcl 108 7,045 $2,405.66 25
Dutasteride Dutasteride 105 8,910 $3,988.88 29
Gemtesa Vibegron 62 4,771 $73,148.00 20
Yonsa Abiraterone Acet,submicronized 56 1,680 $531,813.90 โ€”
Gabapentin Gabapentin 38 1,560 $261.33 โ€”
Methylprednisolone Methylprednisolone 31 966 $426.97 โ€”
Potassium Citrate Er Potassium Citrate 19 870 $779.90 โ€”
Doxazosin Mesylate Doxazosin Mesylate 18 1,020 $248.87 โ€”
Potassium Chloride Potassium Chloride 18 1,440 $493.87 โ€”
Oxybutynin Chloride Oxybutynin Chloride 16 800 $150.35 โ€”
Ciprofloxacin Hcl Ciprofloxacin Hcl 15 108 $50.71 11
Myrbetriq Mirabegron 15 1,284 $18,865.94 โ€”
Trospium Chloride Er Trospium Chloride 12 360 $436.84 โ€”
Zytiga Abiraterone Acetate 12 420 $152,853.69 โ€”
Tolterodine Tartrate Er Tolterodine Tartrate 11 990 $2,159.42 โ€”

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Urology Primary Specialty

NUCC Taxonomy Code: 208800000X

License # reported to NPPES NY 227123

A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: New York Office of the Professions.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
02410933 (NY)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - UROLOGY

Medicare Enrollment ID

I20071205000345

Enrollment State Jurisdiction

NY

PECOS Control ID

4880782275

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Associated Medical Professionals Of Ny Pllc

1226 E Water St, Syracuse, NY 132101155

Phone: 3154784185

Florida Urology Center Pa

300 Clyde Morris Blvd, Ormond Beach, FL 321745956

Phone: 3866735100

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

23 listed
NPI 1386734531

Doctor of Medicine (M.D.)

NPI 1962820977

Doctor of Medicine (M.D.)

Dr. Daniel Alvarez Valero , MD

Radiology - Vascular & Interventional Radiology

NPI 1649791575

Doctor of Medicine (M.D.)

NPI 1710960414

Doctor of Medicine (M.D.)

NPI 1669587903

Doctor of Medicine (M.D.)

Sarah Cote , FNP

Nurse Practitioner - Family

NPI 1992104533

Family Nurse Practitioner

Career & Practice History

NPI enumerated October 05, 2005.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1376530121
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: October 05, 2005
Last Update: June 22, 2012
Sole Proprietor: No

Other Urology Specialists in Syracuse

All Urology Specialists in Syracuse

Mailing Address

1226 E Water St

Syracuse, NY 132101155

Phone: 3154784185

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.